Biomarker– tag –
-
City of Hope Initiates Clinical Trial for Wearable Biosensor Patch to Non-Invasively Monitor Oxygen, CO, Glucose, and Inflammatory Markers Perioperatively
ClinicalTrials.gov (via Power.com) USA Overview City of Hope Medical Center has launched a clinical trial (NCT07612085) to evaluate the feasibility and safety of a wearable biosensor patch for non-invasive, real-time monitoring of oxygen... -
Nanozyme Aptasensors: A Breakthrough for Rapid, High-Sensitivity Detection
AZoNano Australia Overview Nanozyme aptasensors, which ingeniously combine nanozymes and aptamers, represent a highly promising technological advancement for rapid and exceptionally sensitive detection across critical fields like clinica... -
Wearable and Implantable Biosensors Advance Beyond Glucose to Continuous Monitoring of Metabolic, Hormonal, and Inflammatory Biomarkers
Frontiers in Bioengineering and Biotechnology Switzerland Overview Wearable and implantable biosensors are undergoing a paradigm shift, moving beyond continuous glucose monitoring to encompass comprehensive real-time tracking of diverse ... -
Next-Generation Bionic Sensors Integrating Synthetic Biology, Nanomaterials, and AI Revolutionize Precision Medicine and Real-Time Monitoring
MDPI Switzerland Overview Next-generation bionic sensors, integrating synthetic biology, nanomaterials, and artificial intelligence (AI), are poised to revolutionize precision medicine and real-time biomarker monitoring. These wearable a... -
Converging Technologies Drive Digital Biomarker Development in Biotech and Pharma: Wearables, AI, and Telemedicine Integration
Infinix Bio USA Overview The biotechnology and pharmaceutical industries are accelerating digital biomarker development through the integration of wearable devices, mobile health apps, AI/machine learning algorithms, and telehealth platf... -
Optical Nanosensors Evolve for Environmental and Biomedical Applications, Accelerating Personalized Healthcare with Ultrasensitive and Selective Detection
ResearchGate International Overview A comprehensive review highlights the rapid development of optical nanosensors for environmental and biomedical applications. These sensors demonstrate exceptional sensitivity and selectivity for a wid... -
Dual-Target CAR T Therapy for Glioblastoma Drives Broad Immune Activation, NK Cell Response Correlates with Long-Term Survival in Penn Medicine Study
Vertex AI Search USA Overview Researchers at the Perelman School of Medicine and Abramson Cancer Center discovered that direct intra-cerebrospinal fluid (CSF) delivery of a dual-target CAR T-cell therapy induces a broad immune response i... -
AstraZeneca/Daiichi Sankyo’s Enhertu Receives EU Approval as First Tumor-Agnostic HER2-Directed ADC
AstraZeneca UK Overview AstraZeneca and Daiichi Sankyo's antibody-drug conjugate (ADC), Enhertu (trastuzumab deruxtecan), has received EU approval as the first tumor-agnostic HER2-directed therapy for patients with previously treated HER... -
FDA Approves Multiple Novel Oncology Drugs in June 2026, Including ADC for Breast Cancer and Combination for Prostate Cancer
Targeted Oncology USA Overview In June 2026, the U.S. FDA granted several new drug approvals and expanded indications in oncology, notably for Gilead Sciences' antibody-drug conjugate (ADC), sacituzumab govitecan-hziy (Trodelvy), in two ... -
Self-Powered Intelligence Drives Personalized Healthcare: Autonomous Monitoring with Wearable and Implantable Sensors
Oxford Academic UK Overview This article discusses the concept of self-powered intelligence in personalized healthcare, emphasizing the synergistic integration of energy harvesting, circuit design, and intelligent algorithms. These techn...
